Web Search Site Search HCV Patient Assistance Programs (click here for details)   Merck Zepatier Patient Assistance Program (click here for details)   Abbvie - Vikiera Pak Patient Support Program (click here for details)   Sofosbuvir (Sovaldi) - Gilead U.S. Patient Assistance Program (click here for details)   Ryan White Care Act Hepatitis C & B Language (click here for details)   HCV Copayment Assistance - HealthWell Foundation (click here for details)   Current HIV Articles and News Updates     HIV     LATEST UPDATE ON HIV LIPODYSTROPHY: Interview with Dr Grace McComsey   IWCADRH: Regulation of muscle function and mass by the bone-derived hormone osteocalcin - Brain/Bones/Muscle Exercise Connection/Mortality Too/Comorbidities Workshop-NY 9/16 - (06/23/17)   IWCADRH: Clinical Implications of Nonalcoholic Fatty Liver Disease in Patients with HIV Infection - (06/23/17)   Aging with HIV in U.S. Trans NIH Research Themes - (06/22/17)   Using Imaging to Understand the Role of Epicardial Adipose Tissue in HIV-Related Atherosclerosis - (06/22/17)   Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection (13%) - (06/22/17)   Types of Myocardial Infarctions in HIV+ - Type 2 vs Type 1 MIs - (06/22/17)   Pharm: Effect of cobicistat on tenofovir disoproxil fumarate (TDF) durability: is it time to rethink at TAF trials? - Mark Mascolini (06/21/17)   TAF / ATV-Cobi / FTC PK, Interaction - (06/21/17)   TAF 10/25mg VS TDF Plasma Exposures - (06/21/17)   More HIV Articles...         News Updates     ViiV Healthcare's Positive Action Europe Programme awards grants to 14 community-based organisations - (06/14/17)   FDA Approves Generic Truvada - (06/12/17)   America's Hidden H.I.V. Epidemic - (06/09/17)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     EASL: Summary from EASL 2017 for Hepatitis C - Global implementation of Hepatitis C (HCV) treatment: What are the successes, what are the remaining challenges? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany - (06/01/17)   CROI: Summary from CROI 2017 for viral Hepatitis HCV - elimination on its way: dream or emerging reality? - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany   New CDC Hepatitis Surveillance Report - 33,900 New HCV Infections - (06/23/17)   Clinical effects of antivirals for hepatitis C: context is critical - Editorial - (06/23/17)   Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial - (06/23/17)   Two new medicines recommended for the treatment of chronic hepatitis C - EMA - (06/23/17)   European CHMP Adopts Positive Opinion for Gilead's Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes - (06/23/17)   AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) - (06/23/17)   More Hep C Articles...         Hepatitis B     DAA / HBV Reactivation - Making Do With What We Have - Editorial - (06/07/17)   Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System - (05/30/17)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 2017 Conferences - key HIV & Hepatitis related meetings   not necessarily listed here in order of date being held.   2nd Global HIV Clinical Forum: Integrase Inhibitors - Paris July 22 2017 before IAS   19th Intl Workshop on Co-morbidities and Adverse Drug Reactions in HIV - Milan, October 2017 - October 23-25   EASL - 1st NAFLD Summit Nov 2017 Virology Education Meetings 2017 http://www.virology-education.com/ NASH Biomarkers 5-6 May 2017 Washington D.C., USA INTEREST 16-19 May 2017 Malawi, Africa ACHA 20-21 May 2017 Shenzhen, China APACC 1-3 June 2017 Hong Kong European Meeting on HIV & Hepatitis 7-9 June 2017 Rome, Italy International Workshop on Clinical Pharmacology of Antiviral Therapy 14-16 June 2017 Chicago, USA   Onze masterclasses: Post CROI Symposium 21 maart 2017, Utrecht HIV/HCV Masterclass voor apothekers april 2017 - november 2017, Utrecht HIV Health in Clinical Practice maart - juni 2017, Utrecht   11 February 2017 - 12 February 2017 Renaissance Seattle Hotel, Seattle, WA, USA http://www.virology-education.com/event/upcoming/7th-hiv-women-workshop/ http://www.croiconference.org/ http://www.apasl2017.org/#/ http://www.hivresistance2017.co.za/ http://www.bhiva.org/AnnualConference2017.aspx http://hepatitiscommunitysummit.eu/programme/ https://ilc-congress.eu/ http://www.easl-2017.org/index.html https://hivhepamericas.org/ McCormick Place in Chicago, IL, USA, from 6th to 9th May, 2017 http://ddw2017.org/index.php http://www.viral-hep.org/ 14 - 16 June 2017 in Chicago, IL, USA. http://www.virology-education.com/event/upcoming/18th-international-workshop-clinical-pharmacology-antiviral-therapy/ http://www.ias2017.org/ http://www.asm.org/index.php/asm-microbe-2017 http://www.virology-education.com/event/upcoming/15th-european-meeting-hiv-hepatitis-2017/ http://www.idweekinternational.com/Home.aspx   18 October 2017 in Toronto, Canada http://www.virology-education.com/event/upcoming/international-hbv-cure-workshop-2017/ October 2-3 2017 likely in New York City http://www.virology-education.com/event/upcoming/8th-hiv-aging-workshop-2017/ https://www.intmedpress.com/comorbidities/ http://www.eacs-conference2017.com/ http://www.aasld.org/events-professional-development/liver-meeting International Viral Hepatitis Elimination Meeting (IVHEM) 2017 17-18 November 2017, Amsterdam, The Netherlands http://www.virology-education.com/event/upcoming/ivhem2017/ Dec 3-8 2017 Big Island, Kona, Hawaii http://www.virology-education.com/event/upcoming/hep-dart-2017/ 18th International Workshop on Clinical Pharmacology of Antiviral Therapy June 14-17, 2017 Chicago, Ill.   The International Liver Congress™ EASL 2017 - European Association for the Study of the Liver Amsterdam, The Netherlands. 2017   26th Conference of the Asian Pacific Association for the Study of the Liver 2017 APASL, Feb 15-19 Shanghai, China   CROI 2017 - Conference on Retroviruses and Opportunistic Infections (CROI) February 13-16, 2017, Seattle WA   AASLD The Liver Meeting Boston MA November 2016   IDWeek 2016, October 26-30, 2016, New Orleans   HIV Glasgow 23-26 October 2016 Glasgow, UK   HIV Research for Prevention (HIVR4P) October 17-19, 2016 Chicago   7th International Workshop on HIV and Aging September 26-27, 2016 Washington, DC   Paris Special EASL Meeting Pais, France September 23-24, 2016   18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV, September 12-13, 2016, New York   International AIDS Conference Durban, South Africa July 18-22, 2016   ASM/ICAAC June 16-20 2016 Boston MA   17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy June 8-10, 2016, Washington DC   DDW - Digestive Disease Week 2016 San Diego, CA May 16-19, 2016   The International Liver Congress™ EASL - European Association for the Study of the Liver Barcelona, Spain 13-17 April 2016   Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA   APASL 25th Conference of the Asian Pacific Association for the Study of the Liver Feb 20-24 2016, Tokyo, Japan   HEPDART 2015: Frontiers in Drug Development for Viral Hepatitis December 6-10 2015 Wailea, HI   66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015   (IWCADRH) 17th Intl Workshop on Comorbidities and Adverse Drug Reactions in HIV Oct 20-22 2015, Barcelona, Spain   15th European AIDS Conference (EACS) October 21-24, 2015 Barcelona   IDSA/IDWeek October 7-11 2015 San Diego   6th International Workshop on HIV and Aging October 5-6, 2015 Washington, DC   ICAAC 2015 55th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2015, San Diego, CA   IAS 2015: 8th IAS Conference on HIV Pathogenesis Treatment and Prevention Vancouver Canada 18-22 July 2015   16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 26-28, 2015 Washington, DC   DDW - Digestive Disease Week 2015 May 16-19, 2015 Washington DC United States   EASL - The International Liver Congress 2015 50th Annual Meeting of the European Association for the Study of the Liver Vienna, Austria April 22-26   The 24th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2015) Istanbul, Turkey, March 12-15, 2015   22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015   65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014   HIV Drug Therapy Glasgow November 2-6, 2014 Glasgow, UK   5th International Workshop on HIV and Aging. October 21-22, 2014 Baltimore   ACG Annual Scientific Meeting Philadelphia, PA, October 20, 2014   16th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV Philadelphia USA Oct 6-8, 2014   ID Week Oct 8-12 2014 Philadelphia   AASLD/EASL Special Conference on Hepatitis C New York City, New York September 12 - 13   ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2014 Washington, DC   20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   14th European AIDS Conference Oct 16-19 2013 Brussels, Belgium   ID Week October 2-6, 2013 San Francisco   53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13 2013, Denver CO   IAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30 - July 3 2013 Kuala Lumpur, Malaysia   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Support Provided by: Abbvie, Bristol-Myers Squibb, Genentech, Gilead, Janssen Therapeutics, Merck, Roche, & ViiV   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377